Your account is not claimed yet. You can sign up with ORCID to claim your account.

Marwa F Harras

Years Active: 2019-2023
Publications (10 Years): 5

Al-Azhar University

Al-Azhar University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Al-Azhar University

Egypt

Lecturer :: Pharmaceutical Chemistry

Education History

Al-Azhar University

Egypt

PHD

Publications

Thoraya A Farghaly, Eman M H Abbas, Mariam A Al-Sheikh, Hanadi Y Medrasi, Ghada S Masaret, Rami Adel Pashameah, Jihan Qurban, Marwa F Harras
Synthesis of tricyclic and tetracyclic benzo[6,7]cycloheptane derivatives linked morpholine moiety as CDK2 inhibitors. Drug development research (2023)
Najla A Altwaijry, Rehab Sabour, Mona H Ibrahim, Omkulthom Al Kamaly, Omeima Abdullah, Marwa F Harras
Design, synthesis, and anti-hepatocellular carcinoma of thiopyrimidine/chalcone hybrids as dual STAT3/STAT5 inhibitors. RSC medicinal chemistry 14 (10) (2023)
Omkulthom M Alkamaly, Najla Altwaijry, Rehab Sabour, Marwa F Harras
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives. Archiv der Pharmazie 354 (4) (2020)
Rehab Sabour, Marwa F Harras, Omkulthom Mohamed Al Kamaly, Najla Altwaijry
Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers. Molecules (Basel, Switzerland) 25 (21) (2020)
Marwa F Harras, Rehab Sabour, Omkulthom Mohamed Alkamali
Discovery of new non-acidic lonazolac analogues with COX-2 selectivity as potent anti-inflammatory agents. MedChemComm 10 (10) (2019)

Marwa F Harras.css-eqlu8i{font-size:small;padding-left:4px;}